Ionis Pharmaceuticals | IONS - Operating Expenses


Ionis Pharmaceuticals reported $316.9M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Agios Pharmaceuticals USD 129.75M 9.76M Sep/2025
Alnylam Pharmaceuticals USD 881.04M 91.16M Sep/2025
Arrowhead Research USD 212.37M 19.05M Sep/2025
Astellas Pharma JPY 419.91B 6.66B Sep/2025
BioMarin Pharmaceutical USD 807.82M 259.3M Sep/2025
Celltrion KRW 724.99B 6B Sep/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Divis Laboratories Ltd INR 19.4B 1.47B Sep/2025
Exelixis USD 341.4M 13.29M Sep/2025
Halozyme Therapeutics USD 136.34M 13.06M Sep/2025
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 10.02M 9.78M Jun/2025
Moderna USD 1.28B 232M Sep/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025
Neurocrine Biosciences USD 555.6M 13.7M Sep/2025
Novartis USD 9.86B 115M Sep/2025
OPKO Health USD 205.19M 11.6M Sep/2025
Organigram Holdings CAD 108.11M 17.03M Sep/2025
Pfizer USD 92.8B 82.47B Sep/2025
Pharma Mar EUR 39.62M 7.34M Sep/2025
PTC Therapeutics USD 207.52M 6.21M Sep/2025
Qiagen NV USD 395.29M 2.28M Sep/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sarepta Therapeutics USD 462.23M 33.28M Sep/2025
Sartorius EUR 693.1M 29.4M Sep/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tilray USD 237.52M 17.34M Sep/2025
Ultragenyx Pharmaceutical USD 330.82M 56.44M Sep/2025
Vertex Pharmaceuticals USD 1.84B 27.1M Sep/2025
Zz Pientze Pharmaceu CNY 1.55B 129.66M Sep/2025